Literature DB >> 10333449

Hyperbaric oxygen in the treatment of life-threatening soft-tissue infections.

L A Clark1, R E Moon.   

Abstract

Necrotizing soft-tissue infections are rapidly spreading bacterial infections that account for a relatively small proportion of infections, but are aggressive in nature and nearly uniformly fatal if left untreated. Prompt recognition, antibiotic therapy, aggressive surgical debridement, and hyperbaric oxygen (HBO) therapy have reduced the mortality resulting from these infections. Oxygen, at increased pressures, augments tissue oxygen partial pressure, allowing increased bacterial killing by providing substrate for the formation of oxygen free radicals and augmenting respiratory burst. During the healing process, hyperoxia causes increased formation of capillaries for oxygen, nutrient, and antibiotic delivery, leading to increased efficacy of some antibiotics in the high oxygen environment, and possibly more rapid overall wound healing. Although there are no randomized trials of HBO in these infections, in vitro data and meta-analysis of clinical cases strongly support the use of HBO.

Entities:  

Mesh:

Year:  1999        PMID: 10333449

Source DB:  PubMed          Journal:  Respir Care Clin N Am        ISSN: 1078-5337


  14 in total

Review 1.  Wound microbiology and associated approaches to wound management.

Authors:  P G Bowler; B I Duerden; D G Armstrong
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample.

Authors:  Chai R Soh; Ricardo Pietrobon; John J Freiberger; Sophia T Chew; Dimple Rajgor; Mihir Gandhi; Jatin Shah; Richard E Moon
Journal:  Intensive Care Med       Date:  2012-04-20       Impact factor: 17.440

Review 3.  Adjunctive hyperbaric oxygen for necrotizing fasciitis.

Authors:  Denny Levett; Michael H Bennett; Ian Millar
Journal:  Cochrane Database Syst Rev       Date:  2015-01-15

4.  Role of hyperbaric oxygen therapy in the treatment of postoperative organ/space sternal surgical site infections.

Authors:  Fabio Barili; Gianluca Polvani; Veli K Topkara; Luca Dainese; Faisal H Cheema; Maurizio Roberto; Moreno Naliato; Alessandro Parolari; Francesco Alamanni; Paolo Biglioli
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

5.  A different approach to the management of necrotizing fasciitis in neonates: hyperbaric oxygen.

Authors:  Secil Aydinoz; Senol Yildiz
Journal:  Int Wound J       Date:  2007-03       Impact factor: 3.315

Review 6.  Antimicrobial strategies centered around reactive oxygen species--bactericidal antibiotics, photodynamic therapy, and beyond.

Authors:  Fatma Vatansever; Wanessa C M A de Melo; Pinar Avci; Daniela Vecchio; Magesh Sadasivam; Asheesh Gupta; Rakkiyappan Chandran; Mahdi Karimi; Nivaldo A Parizotto; Rui Yin; George P Tegos; Michael R Hamblin
Journal:  FEMS Microbiol Rev       Date:  2013-07-25       Impact factor: 16.408

7.  Hyperbaric oxygen therapy in a patient with autosomal dominant polycystic kidney disease with a perinephritic abscess.

Authors:  Jorge Vega; Helmuth Goecke; Francisco Manriquez; Carlos Escobar; Max Escobar; Christian Videla; Mario Santamarina; Carlos Echeverria; Francisco Javier Guarda
Journal:  Clin Exp Nephrol       Date:  2010-10-01       Impact factor: 2.801

8.  Streptococcal necrotising fasciitis from diverse strains of Streptococcus pyogenes in tropical northern Australia: case series and comparison with the literature.

Authors:  Marilyn Hassell; Peter Fagan; Phillip Carson; Bart J Currie
Journal:  BMC Infect Dis       Date:  2004-12-16       Impact factor: 3.090

9.  Evaluation of the Wound Healing Potential of Achillea biebersteinii Afan. (Asteraceae) by In Vivo Excision and Incision Models.

Authors:  Esra Küpeli Akkol; Ufuk Koca; Ipek Pesin; Demet Yilmazer
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-16       Impact factor: 2.629

10.  Curcuma purpurascens BI. rhizome accelerates rat excisional wound healing: involvement of Hsp70/Bax proteins, antioxidant defense, and angiogenesis activity.

Authors:  Elham Rouhollahi; Soheil Zorofchian Moghadamtousi; Fatemeh Hajiaghaalipour; Maryam Zahedifard; Faezeh Tayeby; Khalijah Awang; Mahmood Ameen Abdulla; Zahurin Mohamed
Journal:  Drug Des Devel Ther       Date:  2015-10-27       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.